- Open Access
Changing trends in mastitis
Irish Veterinary Journalvolume 62, Article number: S59 (2009)
The global dairy industry, the predominant pathogens causing mastitis, our understanding of mastitis pathogens and the host response to intramammary infection are changing rapidly. This paper aims to discuss changes in each of these aspects. Globalisation, energy demands, human population growth and climate change all affect the dairy industry. In many western countries, control programs for contagious mastitis have been in place for decades, resulting in a decrease in occurrence of Streptococcus agalactiae and Staphylococcus aureus mastitis and an increase in the relative impact of Streptococcus uberis and Escherichia coli mastitis. In some countries, Klebsiella spp. or Streptococcus dysgalactiae are appearing as important causes of mastitis. Differences between countries in legislation, veterinary and laboratory services and farmers' management practices affect the distribution and impact of mastitis pathogens. For pathogens that have traditionally been categorised as contagious, strain adaptation to human and bovine hosts has been recognised. For pathogens that are often categorised as environmental, strains causing transient and chronic infections are distinguished. The genetic basis underlying host adaptation and mechanisms of infection is being unravelled. Genomic information on pathogens and their hosts and improved knowledge of the host's innate and acquired immune responses to intramammary infections provide opportunities to expand our understanding of bovine mastitis. These developments will undoubtedly contribute to novel approaches to mastitis diagnostics and control.
Trends in the Industry
The dairy industry worldwide has achieved many significant advances over the last fifty years, with knowledge-based genetic selection and optimised nutrition playing important roles in the delivery of increased milk yields of improved quality in most breeds . Increasingly, the health and welfare of dairy cattle is seen as vital to maximise profitability and to enhance public perception of modern dairy systems [86, 112]. The next few decades are likely to present complex challenges for dairy farmers. Many of these challenges will result from national or international policies and from commercial decisions made by leaders in different countries around the world.
The world population is anticipated to reach nine billion people by 2050. The highest rate of growth is likely to be in developing countries in Africa and Asia, while the population of continents such as Europe should remain relatively stable . More food than that which is currently being produced will be required to feed the world population in the future. The rate of growth in demand for agricultural products has declined from 2.2% per year over the last 30 years to an anticipated 1.5% per year until 2030 . Growth is largely comprised of a higher demand for meat and milk products by increasingly wealthy countries such as India and China . The increased demand for products derived from livestock is not however restricted to richer countries, as in some of the poorest communities in the world, production of crops or vegetables are unsustainable, resulting in heavy reliance on milk and meat . In many of these countries there is an increasing awareness of the benefits to humans of consumption of even very small amounts of protein, especially by the young  and the immunocompromised .
The world is now a global marketplace with many primary commodities and processed products travelling thousands of miles from production to consumption. The incentives for production are evolving with the decoupling of EU subsidies for meat production, the changes in handling of milk quota within the EU, and the ongoing negotiations on world trade under the General Agreements on Tariffs and Trade http://www.wto.org. The UK was 59.3% self-sufficient in food production in 2008, in comparison to 70.6% between 1995 and 1997 . While this trend towards reduced self-sufficiency was seen as acceptable by some government departments, more recent debate has suggested that the UK public may be increasingly interested in issues of food security and supply. The last few years have seen a decline in the milk price in the UK. In the spring of 2007, prices began to increase and a price of 25.62 pence per litre was reported in February 2008. The reasons for this relatively sudden increase in price probably included flooding in the UK, concern about the reliability of supply from major retailers and an increase in global demand for liquid milk and dairy products http://www.defra.gov.uk.
Current concerns about global warming and the adverse effect of greenhouse gases have influenced the perception of livestock farming, including the dairy industry. Approximately 10% of the total EU greenhouse gas emission has been attributed to agriculture . Dairy cattle have also been associated with poor water quality arising from nitrate and phosphate excretion in some heavily-grazed areas. Opinions expressed on the competition between the use of grain as foodstuffs for humans or cattle, or for biofuels are intense and varied, and are at least in part driven by a 60% increase in cereal prices since 2005 . The significant demand for grain for whatever purpose adds pressure to an already severely pressurised dairy industry. This is likely to lead to further reductions in farm numbers with a resulting increase in the average herd size in surviving units. Climate change has been predicted to affect human morbidity and mortality significantly  and is likely to reduce the area of landmass available for agricultural purposes due to drought or flooding in many regions of the world. The Intergovernmental Panel on Climate Change (IPCC) has published detailed assessments of the effects, possible causes and options for mitigation of climate change http://www.ipcc.ch. Yet another possible factor potentially adversely affecting production and trade of milk and milk products is the risk of agroterrorism aimed at the contamination or adulteration of food producing animals or their products [162, 29].
In Europe and North America, current market demand and price for organic milk encourage dairy producers to consider organic production to improve the economic viability of their farm operations . Milk from herds managed organically or conventionally, with or without use of recombinant bovine somatotropin (rbST), is similar in composition [51, 52, 160]. There are, however, perceived nutritional and taste benefits among consumers of organic milk . Environmental and health benefits are also cited as reasons for consumption of organic milk , and consumers are willing to pay a high price for organic or rbST-free milk . On the other hand, environmental benefits as well as animal health benefits have been attributed to use of rBST in milk production [4, 30]. Animal health did not appear to differ between organic and non-organic farms in the UK . Udder health was better in organic than conventional herds in Sweden , whereas poor udder health caused more culling in organic than conventional herds in Switzerland . Comparison of disease rates between conventional and organic herds can be difficult because perception and detection of disease is influenced by management system . Despite the media attention devoted to organic dairy products and large relative increases in demand for organic dairy products, consumption of organic products is mostly limited to affluent consumers, and organic consumption constitutes a small segment of total dairy consumption .
The dilemma, which the dairy industry will have to face, is how to maximise production without compromising welfare, while reducing the impact of carbon emissions from dairy cattle. An important aspect of achieving these aims is to focus on overall lifetime productivity of cattle, rather than on traditional annual targets . To achieve this aim, a reduction in morbidity and mortality due to preventable and prevalent endemic diseases is needed, one such disease being mastitis. If this is to become a reality, increased efforts are required in the speed and accuracy of detection of mastitis, better targeting of therapy, and improved management and decision making in prevention of exposure to pathogens and avoidance of significant risk factors for disease . If successful, a holistic approach to preventing and controlling mastitis may benefit communities across the world, in both nutritional and environmental terms.
Trends at Pathogen Level
In most countries, the major mastitis pathogens are Streptococcus agalactiae, Streptococcus dysgalactiae and Streptococcus uberis, Staphylococcus aureus, and Escherichia coli. The word "major" reflects their considerable impact on cow health, milk quality and productivity. When the standard mastitis prevention programme was developed in England , Gram-positive pathogens such as Streptococcus and Staphylococcus species were the predominant causative agents of mastitis. Many infections caused by these pathogens were subclinical and chronic. The standard mastitis prevention programme aimed to reduce the prevalence of such infections by limiting the number of new infections and the duration of infections, recognizing that incidence and duration are the driving forces behind prevalence . Implementation of these measures lead to a reduction in prevalence of Strep. agalactiae, Strep. dysgalactiae, Staph. aureus, and, to a lesser extent, Strep. uberis in individual herds . As more herds implement the standard control measures, pathogen populations at regional or national level start to shift. In some European countries, e.g. Belgium, Denmark, Norway and the UK, occurrence of Strep. agalactiae is now sporadic [6, 122, 25, 127]. In other areas, Strep. agalactiae is still quite common, e.g. in parts of Europe [Germany: 29% of herds positive ] and the Americas [Brazil: 60% of herds positive ; Uruguay: 11% of herds positive ; New York, USA: 10% of cows positive ]. Subclinical mastitis constitutes a major source of economic loss for dairy farms due to unrealised production potential and decreased milk quality [77, 78]. The feasibility  and economic benefit [167, 50, 53] of Strep. agalactiae control have been demonstrated repeatedly. This should provide every producer with the incentive to control Strep. agalactiae mastitis, and to use resources for milk production in a more efficient manner. In reality, motivation of producers to control mastitis may depend on bonus and penalty systems [36, 3, 118]. Regulatory limits for bulk milk somatic cell counts (BMSCC), which reflect mastitis prevalence in a herd , differ between countries or are entirely lacking. In Colombia, for example, the dairy industry cannot keep up with current demand. The need for milk quantity outweighs the need for milk quality, and there is currently no legislation or laboratory capacity to regulate and measure BMSCC in Colombia. Producers' ability to control mastitis will depend on access to knowledge, diagnostic facilities, and animal health products. An increasing number of cows are milked in Latin America or by Hispanic milkers in the USA. To provide Spanish-speakers with access to information on mastitis control, a growing number of organisations provide bi-lingual milker training and translation of educational materials [119, 129, 155].
In parallel with the decreases in national average BMSCC and prevalence of Strep. agalactiae, a decrease in prevalence of Staph. aureus has been seen in some countries. In Finland, BMSCC decreased from 320,000 cells/ml in 1990 to 180,000 cells/ml in 1995 and Staph. aureus prevalence decreased from 31% to 17% of isolations . As BMSCC and prevalence of major pathogens decrease, the relative importance of other organisms, particularly coagulase negative staphylococci (CNS), increases. In the Netherlands, the prevalence of CNS among bacterial isolates from milk samples increased from 16.2% in 1999 to 42.2% in 2004 for subclinical mastitis, and from 7.3% to 14.1% for clinical mastitis . CNS are now among the most commonly isolated organisms from milk samples of cows with subclinical mastitis in many countries [131, 122, 150, 25]. In 2007, the first international symposium on CNS in bovine mastitis was organised, reflecting the increasing recognition of the potential importance of this group of pathogens . Molecular methods for identification of CNS provide accurate tools for epidemiological studies at CNS species level and future development of species-specific recommendations for treatment and prevention of CNS mastitis .
Despite improvements in control of subclinical mastitis, control of clinical mastitis continues to constitute a major challenge . The main organisms associated with clinical mastitis in England and Wales are E. coli and Strep. uberis [106, 126, 25]. A steady increase in relative importance of Strep. uberis can be seen over the decades, with 15, 17, 21 and 24.5% of clinical mastitis cases attributed to this species in 1969, 1980, 1993 and 2005, respectively [116, 27, 75, 25]. When accounting for the incidence of clinical mastitis per 100 cows per year, however, the absolute incidence of Strep. uberis mastitis decreased from 21 cases per 100 cows in 1969 , to only seven or eight cases per 100 cows in 1980  and 1993 . In recent years, reported Strep. uberis incidence has increased again, with 16 cases/100 cows/year reported for 2005 . The second most common group of pathogens causing clinical mastitis in England and Wales consists of E. coli and other Enterobacteriaceae [106, 25]. In New Zealand, as in the UK, Strep. uberis is the most common pathogen associated with clinical mastitis, but in contrast to the situation in the UK, E. coli mastitis is rarely observed . In Norway, neither Strep. uberis nor E. coli are commonly found. Rather, Staph. aureus and Strep. dysgalactiae are the most common causes of clinical mastitis . Staphylococcus aureus is the main pathogen associated with clinical mastitis in The Netherlands, followed by E. coli and Strep. dysgalactiae . Mycoplasma [63, 59] and Klebsiella [76, 114, 125] mastitis are major concerns in the USA. Faecal shedding of Klebsiella is thought to contribute to exposure and mastitis incidence in dairy herds in the USA [113, 114]. By contrast, Klebsiella mastitis outbreaks are only occasionally reported from Europe and they are predominantly associated with contaminated sawdust bedding [159, 137]. Mycoplasma mastitis is only occasionally reported from Europe [20, 151]. Increasingly, milk samples from clinical mastitis cases are culture-negative. Culture-negative samples were obtained from approximately 25 to 30% of clinical cases in studies in the UK [106, 25] and the USA . It has been proposed that culture negative cases should be attributed to coliform organisms, and that our diagnostic methods and criteria, which were developed for detection of chronic, subclinical infections, need to be updated to be appropriate for the changed spectrum of mastitis pathogens . Use of PCR based methods may also contribute to improved mastitis diagnostics, e.g., through increased sensitivity of detection of Staph. aureus  or organisms that are non-viable or difficult to culture .
Considering that different pathogens are the predominant cause of clinical mastitis in different countries, mastitis controls will need to be developed to meet the specific requirements of an individual country or segment of the dairy industry. Some mastitis control strategies, e.g., vaccination against coliform mastitis, are widely adopted in one country (USA) but may not be available in other countries (e.g, The Netherlands) and not even relevant elsewhere (New Zealand, Norway). Targeted intervention strategies are being developed and implemented in a number of countries ([65, 87], http://www.countdown.org.au). Significant improvements in udder health have been reported , but adoption and success rates depend on farmer motivation and behaviour . Insight into socioeconomic factors that motivate farmers to control mastitis may be as important as scientific or technical knowledge to improve uptake of mastitis control measures .
Trends at strain Level
The application of molecular or DNA-based methods in mastitis research and diagnostics has contributed to an increased understanding of mastitis epidemiology and control options. Using these methods, isolates belonging to a bacterial species can be differentiated at the subspecies or strain level, allowing for improved recognition of sources and transmission routes of pathogens .
Streptococcus agalactiae is the quintessential contagious mastitis pathogen. It mostly causes subclinical infections and implementation of the standard mastitis prevention programme has all but eradicated this organism from several countries in Western Europe. Occasionally, clinical Strep. agalactiae mastitis is observed in herds with good control of contagious mastitis, as evidenced by low BMSCC (<150,000 cells/ml) . Clinical episodes of Strep. agalactiae mastitis can also be induced experimentally . They are generally short-lived and do not result in transmission of the pathogen in the herd. Occurrence of Strep. agalactiae in bulk tank milk from herds without evidence for transmission or presence of the pathogen in individual cow has been attributed to cross contamination between loads of milk . Other authors attribute the occurrence of incidental clinical mastitis and the presence of Strep. agalactiae in bulk tank milk obtained from Strep. agalactiae-free animals to introduction of human Strep. agalactiae strains . Strep. agalactiae or Group B Streptococcus (GBS) is highly prevalent in humans, with carriage rates of 30% or more in the urogenital and distal gastrointestinal tracts of women [97, 103, 68] and close to 25% in men . Maternal carriage of Strep. agalactiae may result in neonatal infection, with subsequent sepsis, meningitis, permanent neurological damage, or death of newborns. Human and bovine isolates largely constitute genetically distinct subpopulations within the bacterial species [19, 22, 43, 145]. Canine and feline strains of Strep. agalactiae are genetically similar to human rather than bovine strains . A virulent human strain of Strep. agalactiae that is significantly associated with invasive neonatal disease has evolved from bovine strains of Strep. agalactiae . To prevent emergence of additional human-pathogenic strains from a bovine Strep. agalactiae reservoir, it has been suggested that the pathogen should be eradicated from the cattle population . Strep. agalactiae is highly prevalent in humans but relatively rare in UK dairy herds, and its presence in dairy herds may be the result or the cause of its presence in humans. Thus, it is uncertain whether elimination from cattle would be a cost-effective way to prevent human disease due to Strep. agalactiae.
Staphylococcus aureus has been more difficult to control using the standard mastitis prevention programme than Strep. agalactiae. This is due in part to difficulty in diagnosing and curing Staph. aureus infections . In addition, Staph. aureus can be found in many sources, including bovine skin, non-bovine animals and humans, flies, and the barn environment. Strain typing studies show that some cases of Staph. aureus mastitis are not due to contagious transmission but environmental in origin [83, 133, 169, 80]. The incidence of environmental Staph. aureus infections would not be affected by implementation of the standard mastitis prevention programme. Across countries and continents, more than 85% of bovine Staph. aureus mastitis is caused by a genetically closely related subpopulation of the species [58, 142], which is adapted to the bovine host or, more specifically, to the bovine udder . Strains of Staph. aureus differ in their ability to spread from cow to cow [143, 174] or to provoke an increase in somatic cell count , in impact on milk yield , and in response to antimicrobial treatment . The full genome sequences of a number of Staph. aureus strains are now available . This allows for detailed examination of genetic elements or proteins that may be responsible for host or tissue adaptation . An improved understanding of such components may contribute to the development of new intervention strategies to control Staph. aureus mastitis [57, 110]. As for Strep. agalactiae, a virulent strain that poses a potential human health risk has arisen from a subpopulation of bovine Staph. aureus . In addition, methicillin-resistant Staph. aureus in dairy cattle and cattle farmers is an increasing concern [81, 108, 157]. These findings lend new urgency to the need to improve control of Staph. aureus mastitis.
Whilst Staph. aureus is a contagious pathogen more than an environmental pathogen, the reverse is true for Strep. uberis . Strain typing studies have revealed large genetic heterogeneity among Strep. uberis isolates obtained from animals within a single herd, particularly in New Zealand [47, 165, 101, 128], which proves absence of cow-to-cow transmission. In other studies, however, predominant strains of Strep. uberis have been observed within herds [173, 33], which might be explained by contagious transmission. In one outbreak, the milking machine was identified as a likely fomite for such transmission . Alternative explanations for strain predominance include overrepresentation of a strain in the environment, or host-adaptation of a subset of the Strep. uberis population . In studies from New Zealand, several common environmental strains were underrepresented among mastitis causing isolates [95, 128], which argues against environmental strain predominance as a full explanation for strain predominance among bovine isolates. Modern genomic and proteomic methods enable us to explore the host-adaptation hypothesis  as well as potential vaccine targets . They may also help us understand why some Strep. uberis infections respond well to antimicrobial treatment, whereas others do not respond to prolonged intramammary therapy . In vitro, adherence of Strep. uberis and subsequent invasion and survival in mammary epithelial cells has been observed . Such processes could explain persistence of infection and treatment failures, but it is uncertain whether these observations are a reflection of events that take place in vivo . Use of infection models in animals will help to assess the relevance of these experiments and their potential contribution to our knowledge of disease causation and control.
Where Strep. agalactiae may be considered the quintessential contagious pathogen, E. coli can be considered the quintessential environmental pathogen and no evidence for cow-to-cow transmission of E. coli has been published yet. There is, however, emerging evidence for host-adaptation of E. coli. Most E. coli infections occur in early lactation in high producing cows, when immunosuppression through metabolic deficiencies  or extremely low SCC [147, 126] lowers the host's resistance. Infections tend to result in acute and often severe clinical mastitis with removal of the pathogen or removal of the cow as the two most likely outcomes. In other animals, however, recurrent episodes of clinical mastitis are observed, with considerable economic loss as a result . Recurrent clinical episodes may be due to cure and reinfection of a susceptible host. Alternatively, the bacteria and the cow may survive simultaneously, and subclinical episodes of a persistent infection may alternate with clinical episodes. Strain typing studies have confirmed the existence of both mechanisms [44, 45, 24, 42]. Persistence of E. coli infections is associated with invasion and survival of E. coli inside mammary epithelial cells in vitro , a mechanism similar to that proposed for Strep. uberis. Virulence genes typically associated with invasion of diarrhoeagenic and uropathogenic pathogenic E. coli did not account for the invasive behaviour of mastitis-associated E. coli strains and the mechanism of invasion is as yet undetermined . Whole genome comparison of E. coli strains associated with different disease syndromes may reveal genes that are specific to mastitis associated E. coli. Some cases of clinical E. coli mastitis that are observed in lactation are the result of infections that took place in the dry period , implying that the dry period rather than peak lactation can be a critical time for control of E. coli mastitis. Use of internal teat sealants does not reduce the risk of dry-period infections with coliform bacteria significantly [16, 17]
Through use of genomic and proteomic tools, it will be possible to further explore how different subpopulations of pathogens differ in mechanisms of disease causation and transmission. A more developed understanding of the pathogenesis and epidemiology of bovine mastitis will provide new approaches aimed at improvements in mastitis control. Rapid, effective, and increasingly cost-effective methods of sequencing pathogen genomes have already contributed new information to our understanding of host-pathogen interactions in mastitis. Manipulation of mastitis pathogens using molecular methods such as mutagenesis , and measurement of messenger RNA (transcriptomics), proteins or peptides (proteomics) and networks of metabolites (metabolomics), provide further opportunities to investigate mastitis pathogenesis at pathogen and host level [94, 144, 149, 21].
Trends at Host Level
In many countries, the emphasis on improving dairy production has been to focus on breeds that have particularly high milk yields, especially Holstein, which is the most widespread dairy cattle breed, found in 128 countries worldwide . In the USA, fewer than 5% of dairy cattle belong to breeds other than purebred or grade Holsteins . There has been a decrease in the numbers of more traditional breeds such as Jersey and Guernsey and Alpine breeds, which have lower milk yields but better quality milk than the Holstein breed in terms of benefits to human health or processing qualities [51, 38, 82]. Selection of dairy cattle over the years has been based on phenotypic traits such as teat length, udder placement and 'dairy type', however, increased emphasis on selection of sires for traits such as predicated transmitting ability for somatic cell counts, an indirect measurement of mastitis susceptibility, and for economic traits such as profit index, total economic index and profitable life index, are becoming commonplace [35, 164]. Selection of sires for these traits has increased the rate of change of phenotypic characteristics, for example milk yield and quality, however, this has occurred through selection of a relatively small number of very popular sires, especially within Holstein Friesians. In some animal species, selection of a small number of sires has been associated with genetic bottlenecks [105, 132]. This may result in reduced variation in the offspring, which may in turn have adverse effects on health and welfare. One gene complex which has been long recognised as being associated with mastitis susceptibility or resistance is the Major Histocompatibility Complex, where Class I  were found to be associated with health traits including measurements of somatic cell counts  and Class II  genes have been demonstrated as playing an important role in presenting antigen to cells of the immune system and in response of lymphocytes to mastitis pathogens . More recently, other genes and gene complexes have been shown to play a role in the pathogenesis of mastitis, including Toll-like receptors .
In some countries, priorities such as the adaptability of cows to once a day milking or for specific systems including low input or extensive management, have led to selection for characteristics other than milk yield. There is increasing interest in cross-breeding dairy cattle such as Norwegian Reds with one or more breeds (e.g. Holstein Friesian and/or Normande, Montbeliarde; ) in order to produce dairy cattle with reasonable production levels combined with a reduced susceptibility to some of the main production diseases including mastitis and endometritis . Changing breeding goals also reflect a growing public interest in sustainability of dairy cattle production, with consideration of market economic values and non-market values such as animal welfare [120, 117]. In contrast to the dominance of the Holstein breed in terms of cow numbers and contribution to dairy genetics, certain dairy breeds across the world have had their numbers reduced to such an extent, that their sustainability is threatened. One such example is the Modicana breed of cattle, originating in Sicily where they produce very high quality hard cheese: Ragusano . It is important that a genetic resource for minor breeds is maintained in order to protect against extinction and to ensure that beneficial genes could be re-introduced to the dairy cattle population should they be identified as required. The uncertainty of the direction of the dairy industry in terms of supply and demand, and in light of potential environmental impacts, makes maintenance of diversity in dairy cattle particularly important.
Requirements for liquid milk and dairy products in developing countries will require development of more efficient dairying systems and investment in the application of modern technologies where appropriate. Maintenance of dairy cattle in developing countries poses many challenges, especially breeding cattle, which are resistant to many of the diseases with high mortality such as theileriosis and trypanosomiasis . In East Africa, dairy cattle are principally cross-breeds between European Bos taurus dairy breeds, including Ayrshire, Friesian or Jersey, and indigenous Bos indicus cattle such as Boran or Zebu [109, 84]. The Boran breed which is recognised for its relatively high milk yield compared to other cross-breeds, has been shown to be 3.4 times more likely to be affected by clinical and subclinical mastitis than the Tanzanian Shorthorn Zebu breed . Selection of crossbred dairy cattle on the basis of greater milk yield may therefore need to be combined with an improvement in control programmemes for mastitis to ensure a sustainable industry.
Resistance to mastitis has been associated with both innate  and acquired immunity . Selection of cattle for breeding for mastitis resistance depends on measurement of humoral or cellular assays which are predicted as correlates of protection against intramammary infection [46, 140]. It is increasingly recognised that different mastitis species induce very different inflammatory and immune responses. Examples include the very rapid and relatively short-lived influx of neutrophils following infection with the Gram negative organisms such as E. coli  and the more gradual concentration of lymphocytes, including regulatory T cells in mammary glands infected with Staph. aureus . Host genetics affect disease incidence and severity, and pathogen genetics may influence the host genetic structure. Therefore, the evolutionary impact of the interaction between the host and its pathogens needs to be taken into consideration to fully appreciate implications of breeding strategies aimed at mastitis prevention .
Host responses to intramammary infection differ between pathogen species [10, 8, 9] and pathogen strains. The ability of the host to prevent establishment of new intramammary infections is determined in part by the ability of neutrophils to phagocytose and kill pathogens. Pathogen strains that evade neutrophil killing are more likely to establish infection than those that do not. In vitro, Staph. aureus strains that produce enterotoxins are not killed as efficiently as enterotoxin negative strains . In a large collection of Staph. aureus isolates from three continents, enterotoxin producing strains were overrepresented among isolates that caused clinical mastitis , suggesting that the inability of the host immune system to deal efficiently with these strains results in increased likelihood of clinical disease. Whether it is the enterotoxins themselves that affect the immune response, or other virulence factors encoded by the agr-loci that enterotoxin production tends to be associated with, is not fully understood . For Strep. uberis, differences between strains in their ability to cause clinical mastitis have also been associated with differences in their ability to resist phagocytosis and killing by host neutrophils . Analysis of large international collections of Strep. uberis has shown that isolates that carry the hasA gene, which encodes hyaluronate synthase and contributes to capsule formation, are more likely to cause clinical mastitis than other isolates [33, 128, 152]. Initially, it was thought that capsule mediates resistance of Strep. uberis to phagocytosis and killing by bovine neutrophils , but later studies showed that the presence of capsule is not directly related to the bactericidal action of neutrophils . Thus, the mechanisms underlying strain-specific host-immune responses to Staph. aureus and Strep. uberis remain to be elucidated. Mechanisms underlying strain specific interaction of pathogens with host mammary epithelial cells, as desribed for Strep. uberis  and E. coli  have not been identified either. Further studies are required to compare inter-strain variation in host response.
Summary and Outlook
While this manuscript describes the trends considered by the authors as impacting significantly on the dairy and veterinary industries, many aspects discussed also potentially relate to infections of the mammae of humans and identification of the causes and effects of intramammary disease in lactating women. Breast-feeding mothers are at risk of clinical and possibly subclinical mastitis [153, 60] and infectious mastitis is one of the main causes of premature weaning in lactating women . The current focus on 'One Medicine' by the Centres for Disease Control and Prevention in the USA and the promotion of this approach by the editors of the British Medical Journal and The Veterinary Record  aims to combine research efforts on human and veterinary diseases to provide benefits to all mammals in terms of effective response to terrorism, diseases and natural disasters. Some of the trends appearing in mastitis in dairy cattle raise issues of comparative medicine in addition to the impact of the disease on the availability and benefits of milk to the human population.
Recent scientific developments, specifically in the areas of genomics and proteomics at host and pathogen level, provide exponentially growing opportunities for a deepening of our understanding of mastitis pathogenesis and epidemiology. Whilst it is hoped that such scientific understanding will contribute to mastitis control, social, economic and climatic trends are likely to be the main drivers behind changes in milk production systems and mastitis control. At herd level, motivation of farmers is an essential driver. At the national level, regulatory and economic incentives may be used to drive farmer motivation. At a global level, food and fuel needs and changes in human population size, wealth distribution, climate and land availability and use will be major forces in determining the future of agriculture and dairy farming. Although there are many uncertainties surrounding estimates in anticipated population, climate and land use changes, one thing is clear: more people will need to be provided with animal-based food products using fewer natural resources. Thus, there is an urgent need to increase the efficiency of milk production. Mastitis control is a step towards reaching that goal.
Ahmed M, Ehui S, Mohamed-Saleem MA: Adoption of crossbred cow technologies and increase in food security among smallholder dairy farmers in the East African highlands. J Crop Prod (USA). 2002, 6 (1/2): 319-337. 10.1300/J144v06n01_12.
Alder M, Easton G: Human and veterinary medicine. BMJ. 2005, 330 (7496): 858-859. 10.1136/bmj.330.7496.858.
Allore HG, Erb HN: Partial budget of the discounted annual benefit of mastitis control strategies. J Dairy Sci. 1998, 81 (8): 2280-2292. 10.3168/jds.S0022-0302(98)75808-4.
Allore HG, Erb HN: Simulated effects on dairy cattle health of extending the voluntary waiting period with recombinant bovine somatotropin. Prev Vet Med. 2000, 46 (1): 29-50. 10.1016/S0167-5877(00)00137-9.
American Farm Bureau: Retail food prices up at beginning of 2008. 2008, [Accessed 5 December 2008], [http://www.fb.org/index.php?fuseaction=newsroom.newsfocus%26;year=2008%26;file=nr0327.html]
Andersen HJ, Pedersen LH, Aarestrup FM, et al: Evaluation of the surveillance programme of Streptococcus agalactiae in Danish dairy herds. J Dairy Sci. 2003, 86 (4): 1233-1239. 10.3168/jds.S0022-0302(03)73707-2.
Baba T, Bae T, Schneewind O, et al: Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol. 2008, 190 (1): 300-310. 10.1128/JB.01000-07.
Bannerman DD, Paape MJ, Goff JP, et al: Innate immune response to intramammary infection with Serratia marcescens and Streptococcus uberis. Vet Res. 2004, 35 (6): 681-700. 10.1051/vetres:2004040.
Bannerman DD, Paape MJ, Lee JW, et al: Escherichia coli and Staphylococcus aureus elicit differential innate immune responses following intramammary infection. Clin Diagn Lab Immunol. 2004, 11 (3): 463-472.
Bannerman DD: Pathogen-dependent induction of cytokines and other soluble inflammatory mediators during intramammary infection of dairy cows. 2008
Bar D, Gröhn YT, Bennett G, et al: Effect of repeated episodes of generic clinical mastitis on milk yield in dairy cows. J Dairy Sci. 2007, 90 (10): 4643-4653. 10.3168/jds.2007-0145.
Barkema HW, Schukken YH, Lam TJ, et al: Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J Dairy Sci. 1998, 81 (2): 411-419. 10.3168/jds.S0022-0302(98)75591-2.
Barkema HW, Schukken YH, Zadoks RN: Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci. 2006, 89 (6): 1877-1895. 10.3168/jds.S0022-0302(06)72256-1.
Barlow J, Rauch B, Welcome F, et al: Association between Coxiella burnetii shedding in milk and subclinical mastitis in dairy cattle. Vet Res. 2008, 39 (3): 23-10.1051/vetres:2007060.
Beghin JC: Evolving dairy markets in Asia: recent findings and implications. Food Policy. 2006, 31 (3): 195-200. 10.1016/j.foodpol.2006.03.001.
Berry EA, Hillerton JE: The effect of an intramammary teat seal on new intramammary infections. J Dairy Sci. 2002, 85 (10): 2512-2520. 10.3168/jds.S0022-0302(02)74334-8.
Berry EA, Hillerton JE: Effect of an intramammary teat seal and dry cow antibiotic in relation to dry period length on postpartum mastitis. J Dairy Sci. 2007, 90 (2): 760-765. 10.3168/jds.S0022-0302(07)71560-6.
Bhargava A: Modeling of the effects of maternal nutritional status and socioeconomic variables on the anthropometric and psychological indicators of Kenyan infants from age 0-6 months. Am J Phys Anthropol. 2000, 111 (1): 89-104. 10.1002/(SICI)1096-8644(200001)111:1<89::AID-AJPA6>3.0.CO;2-X.
Bisharat N, Crook DW, Leigh J, et al: Hyperinvasive neonatal group B streptococcus has arisen from a bovine ancestor. J Clin Microbiol. 2004, 42 (5): 2161-2167. 10.1128/JCM.42.5.2161-2167.2004.
Blackburn P, Brooks C, McConnell W, et al: Isolation of Mycoplasma bovis from cattle in Northern Ireland from 1999 to 2005. Vet Rec. 2007, 161 (13): 452-453. 10.1136/vr.161.13.452.
Boehmer JL, Bannerman DD, Shefcheck K, et al: Proteomic analysis of differentially expressed proteins in bovine milk during experimentally induced Escherichia coli mastitis. J Dairy Sci. 2008, 91 (11): 4206-4218. 10.3168/jds.2008-1297.
Bohnsack JF, Whiting AA, Martinez G, et al: Serotype III Streptococcus agalactiae from bovine milk and human neonatal infections. Emerg Infect Dis. 2004, 10 (8): 1412-1419.
Bradley AJ, Green MJ: A study of the incidence and significance of intramammary enterobacterial infections acquired during the dry period. J Dairy Sci. 2000, 83 (9): 1957-1965. 10.3168/jds.S0022-0302(00)75072-7.
Bradley AJ, Green MJ: Adaptation of Escherichia coli to the bovine mammary gland. J Clin Microbiol. 2001, 39 (5): 1845-1849. 10.1128/JCM.39.5.1845-1849.2001.
Bradley AJ, Leach KA, Breen JE, et al: Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales. Vet Rec. 2007, 160 (8): 253-257. 10.1136/vr.160.8.253.
Bradley AJ, Newton H, Green MJ: Use and interpretation of bacteriology in the diagnosis of bovine intramammary infection. Proceedings of the 4th IDF International Mastitis Conference, Maastricht, The Netherlands. 2005, 409-415.
Bramley AJ: Streptococcus uberis udder infection - a major barrier to reducing mastitis incidence. Br Vet J. 1984, 140 (4): 328-335.
Brouillette E, Malouin F: The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect. 2005, 7 (3): 560-568. 10.1016/j.micinf.2004.11.008.
Buttars NK, Young AJ, Bailey D: Adoption of security systems by dairy farms to address bioterrorist threats in the intermountain United States. J Dairy Sci. 2006, 89 (5): 1822-1829. 10.3168/jds.S0022-0302(06)72251-2.
Capper JL, Castañeda-Gutiérrez E, Cady RA, et al: The environmental impact of recombinant bovine somatotropin (rbST) use in dairy production. Proc Natl Acad Sci USA. 2008, 105 (28): 9668-9673. 10.1073/pnas.0802446105.
Chang BS, Bohach GA, Lee SU, et al: Immunosuppression by T regulatory cells in cows infected with staphylococcal superantigen. J Vet Sci. 2005, 6 (3): 247-250.
Chevalier P, Sevilla R, Sejas E, et al: Immune recovery of malnourished children takes longer than nutritional recovery: implications for treatment and discharge. J Trop Pediatr. 1998, 44 (5): 304-307. 10.1093/tropej/44.5.304.
Coffey TJ, Pullinger GD, Urwin R, et al: First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology. Appl Environ Microbiol. 2006, 72 (2): 1420-1428. 10.1128/AEM.72.2.1420-1428.2006.
DEFRA: The Environmental Impact of Livestock Production. Review of Research and Literature. 2008, [Accessed December 7 2008], [http://www.defra.gov.uk/farm/livestock/pdf/envimpacts-livestock.pdf]
Dekkers JC, Gibson JP: Applying breeding objectives to dairy cattle improvement. J Dairy Sci. 1998, 81 (S2): 19-35. 10.3168/jds.S0022-0302(98)70151-1.
Dekkers JC, Van Erp T, Schukken YH: Economic benefits of reducing somatic cell count under the milk quality programme of Ontario. J Dairy Sci. 1996, 79 (3): 396-401. 10.3168/jds.S0022-0302(96)76378-6.
Delgado S, Arroyo R, Martín R, et al: PCR-DGGE assessment of the bacterial diversity of breast milk in women with lactational infectious mastitis. BMC Infect Dis. 2008, 8: 51-10.1186/1471-2334-8-51.
De Marchi M, Dal Zotto R, Cassandro M, et al: Milk coagulation ability of five dairy cattle breeds. J Dairy Sci. 2007, 90 (8): 3986-3992. 10.3168/jds.2006-627.
De Vliegher S, Zadoks RN, Barkema HW: Heifer and CNS mastitis. Vet Microbiol. 2009, 134 (1-2): 1-2. 10.1016/j.vetmic.2008.09.016.
Detilleux JC: Genetic factors affecting susceptibility to udder pathogens. Vet Microbiol Vet Microbiol. 2009, 134 (1-2): 157-164.
Dodd FH, Westgarth DR, Neave FK, et al: Mastitis: the strategy of control. J Dairy Sci. 1969, 52 (5): 689-695. 10.3168/jds.S0022-0302(69)86631-2.
Dogan B, Klaessig S, Rishniw M, et al: Adherent and invasive Escherichia coli are associated with persistent bovine mastitis. Vet Microbiol. 2006, 116 (54): 270-282. 10.1016/j.vetmic.2006.04.023.
Dogan B, Schukken YH, Santisteban C, et al: Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J Clin Microbiol. 2005, 43 (12): 5899-5906. 10.1128/JCM.43.12.5899-5906.2005.
Döpfer D, Almeida RA, Lam TJ, et al: Adhesion and invasion of Escherichia coli from single and recurrent clinical cases of bovine mastitis in vitro. Vet Microbiol. 2000, 74 (4): 331-343. 10.1016/S0378-1135(00)00191-7.
Döpfer D, Barkema HW, Lam TJ, et al: Recurrent clinical mastitis caused by Escherichia coli in dairy cows. J Dairy Sci. 1999, 82 (1): 80-85. 10.3168/jds.S0022-0302(99)75211-2.
Dosogne H, Vangroeneweghe F, Burvenich C: Potential mechanism of action of J5 vaccine in protection against sever bovine coliform mastitis. Vet Res. 2002, 33 (1): 1-12. 10.1051/vetres:2001001.
Douglas VL, Fenwick SG, Pfeiffer DU, et al: Genomic typing of Streptococcus uberis isolates from cases of mastitis, in New Zealand dairy cows, using pulsed-field gel electrophoresis. Vet Microbiol. 2000, 75 (1): 27-41. 10.1016/S0378-1135(00)00184-X.
Duarte RS, Miranda OP, Bellei BC, et al: Phenotypic and molecular characteristics of Streptococcus agalactiae isolates recovered from milk of dairy cows in Brazil. J Clin Microbiol. 2004, 42 (9): 4214-4222. 10.1128/JCM.42.9.4214-4222.2004.
Eberhart RJ, Hutchinson LJ, Spencer SB: Relationships of bulk tank somatic cell counts to prevalence of intramammary infection to indices of herd production. J Food Prot. 1982, 45 (12): 1125-1128.
Edmondson PW: An economic justification of 'blitz' therapy to eradicate Streptococcus agalactiae from a dairy herd. Vet Rec. 1989, 125 (24): 591-593.
Ellis KA, Innocent G, Grove-White D, et al: Comparing the fatty acid composition of organic and conventional milk. J Dairy Sci. 2006, 89 (6): 1938-1950. 10.3168/jds.S0022-0302(06)72261-5.
Ellis KA, Monteiro A, Innocent GT, et al: Investigation of the vitamins A and E and beta-carotene content in milk from UK organic and conventional dairy farms. J Dairy Res. 74 (4): 484-491.
Erskine RJ, Eberhart RJ: Herd benefit-to-cost ratio and effects of a bovine mastitis control programme that includes blitz treatment of Streptococcus agalactiae. J Am Vet Med Assoc. 1990, 196 (8): 1230-1235.
FAO: World agriculture 2030: Main findings. 2002, [Accessed December 7 2008], [http://www.fao.org/english/newsroom/news/2002/7833-en.html]
FAO: State of the World's Farm Animal Genetic Resources. 2007, [Accessed December 7 2008], [http://www.fao.org/Ag/AGAInfo/programmemes/en/genetics/documents/AH473e01.pdf]
Field TR, Ward PN, Pedersen LH, et al: The hyaluronic acid capsule of Streptococcus uberis is not required for the development of infection and clinical mastitis. Infect Immun. 2003, 71 (1): 132-139. 10.1128/IAI.71.1.132-139.2003.
Fitzgerald JR, Hartigan PJ, Meaney WJ, et al: Molecular population and virulence factor analysis of Staphylococcus aureus from bovine intramammary infection. J Appl Microbiol. 2000, 88 (6): 1028-1037. 10.1046/j.1365-2672.2000.01071.x.
Fitzgerald JR, Meaney WJ, Hartigan PJ, et al: Fine-structure molecular epidemiological analysis of Staphylococcus aureus recovered from cows. Epidemiol Infect. 1997, 119 (2): 261-269. 10.1017/S0950268897007802.
Fox LK, Kirk JH, Britten A: Mycoplasma mastitis: a review of transmission and control. J Vet Med B Infect Dis Vet Public Health. 2005, 52 (4): 153-60.
Foxman B, D'Arcy H, Gillespie B, et al: Lactation mastitis: occurrence and medical management among 946 breastfeeding women in the United States. Am J Epidemiol. 2002, 155 (2): 103-114. 10.1093/aje/155.2.103.
Freeman AR, Meghen CM, Machugh DE, et al: Admixture and diversity in West African cattle populations. Mol Ecol. 2004, 13 (11): 3477-3487. 10.1111/j.1365-294X.2004.02311.x.
Gianneechini R, Concha C, Rivero R, et al: Occurrence of clinical and sub-clinical mastitis in dairy herds in the West Littoral Region in Uruguay. Acta Vet Scand. 2002, 43 (4): 221-230. 10.1186/1751-0147-43-221.
González RN, Wilson DJ: Mycoplasmal mastitis in dairy herds. Vet Clin North Am Food Anim Pract. 2003, 19 (1): 199-221. 10.1016/S0749-0720(02)00076-2.
Graber HU, Casey MG, Naskova J, et al: Development of a highly sensitive and specific assay to detect Staphylococcus aureus in bovine mastitic milk. J Dairy Sci. 2007, 90 (10): 4661-4669. 10.3168/jds.2006-902.
Green MJ, Leach KA, Breen JE, et al: National intervention study of mastitis control in dairy herds in England and Wales. Vet Rec. 2007, 160 (9): 287-293. 10.1136/vr.160.9.287.
Guinane CM, Sturdevant DE, Herron-Olson L, et al: Pathogenomic analysis of the common bovine Staphylococcus aureus clone (ET3): emergence of a virulent subtype with potential risk to public health. J Infect Dis. 2008, 197 (2): 205-213. 10.1086/524689.
Hamilton C, Emanuelson U, Forslund K, et al: Mastitis and related management factors in certified organic dairy herds in Sweden. Acta Vet Scand. 2006, 17 (48): 11-10.1186/1751-0147-48-11.
Hansen SM, Uldbjerg N, Kilian M, et al: Dynamics of Streptococcus agalactiae colonisation in women during and after pregnancy and in their infants. J Clin Microbiol. 2004, 42 (1): 83-89. 10.1128/JCM.42.1.83-89.2004.
Heins BJ, Hansen LB, Seykora AJ: Production of pure Holstein versus crossbreds of Holstein with Normande, Montbeliarde, and Scandinavian Red. J Dairy Sci. 2006, 89 (7): 2799-2804. 10.3168/jds.S0022-0302(06)72356-6.
Heringstad B, Klemetsdal G, Steine T: Selection responses for disease resistance in two selection experiments with Norwegian red cows. J Dairy Sci. 2007, 90 (5): 2419-2426. 10.3168/jds.2006-805.
Herron-Olson L, Fitzgerald JR, Musser JM, et al: Molecular correlates of host specialisation in Staphylococcus aureus. PLoS ONE. 2007, 2 (10): e1120-10.1371/journal.pone.0001120.
Hill H, Lynchehaun F: Case Study Organic milk: attitudes and consumption patterns. British Food J. 2002, 104 (7): 526-542. 10.1108/00070700210434570.
Hillerton JE, Bramley AJ, Staker RT, et al: Patterns of intramammary infection and clinical mastitis over a five year period in a closely monitored herd applying mastitis control measures. J Dairy Res. 1995, 62 (1): 39-50. 10.1017/S0022029900033653.
Hillerton JE, Leigh JA, Ward PN, et al: Streptococcus agalactiae infection in dairy cows. Vet Rec. 2004, 154 (21): 671-672.
Hillerton JE, Shearn MF, Teverson RM, et al: Effect of pre-milking teat dipping on clinical mastitis on dairy farms in England. J Dairy Res. 1993, 60 (1): 31-41. 10.1017/S0022029900027321.
Hoe FG, Ruegg PL: Relationship between antimicrobial susceptibility of clinical mastitis pathogens and treatment outcome in cows. J Am Vet Med Assoc. 2005, 227 (9): 1461-1468. 10.2460/javma.2005.227.1461.
Hortet P, Seegers H: Calculated milk production losses associated with elevated somatic cell counts in dairy cows: review and critical discussion. Vet Res. 1998, 29 (6): 497-510.
Huijps K, Lam TJ, Hogeveen H: Costs of mastitis: facts and perception. J Dairy Res. 2008, 75 (1): 113-120. 10.1017/S0022029907002932.
Jensen NE: Experimental bovine group-B streptococcal mastitis induced by strains of human and bovine origin. Nord Vet Med. 1982, 34 (12): 441-450.
Joo YS, Fox LK, Davis WC, et al: Staphylococcus aureus associated with mammary glands of cows: genotyping to distinguish different strains among herds. Vet Microbiol. 2001, 80 (2): 131-138. 10.1016/S0378-1135(00)00381-3.
Juhász-Kaszanyitzky E, Jánosi S, Somogyi P, et al: MRSA transmission between cows and humans. Emerg Infect Dis. 2007, 13 (4): 630-632. 10.3201/eid1304.060833.
Kamiski S, Ciesliska A, Kostyra E: Polymorphism of bovine beta-casein and its potential effect on human health. J Appl Genet. 2007, 48 (3): 189-198. 10.1007/BF03195213.
Kapur V, Sischo WM, Greer RS, et al: Molecular population genetic analysis of Staphylococcus aureus recovered from cows. J Clin Microbiol. 1995, 33 (2): 376-380.
Karimuribo ED, Fitzpatrick JL, Bell CE, et al: Clinical and subclinical mastitis in smallholder dairy farms in Tanzania: risk, intervention and knowledge transfer. Prev Vet Med. 2006, 74 (1): 84-98. 10.1016/j.prevetmed.2006.01.009.
Kehrli ME, Harp JA: Immunity in the mammary gland. Vet Clin North Am Food Anim Pract. 2001, 17 (3): 495-516.
Kelton DF: Epidemiology: a foundation for dairy production medicine. Vet Clin North Am Food Anim Pract. 2006, 22 (1): 21-33. 10.1016/j.cvfa.2005.12.003.
Lam TJGM, Jansen J, Van den Borne B, et al: A structural approach of udder health improvement via private practitioners: ups and downs. NMC 46th Annual Meeting Proceedings, San Antonio, Texas, USA. 2007, 142-151.
Langford FM, Rutherford KM, Jack MC, et al: A comparison of management practices, farmer-perceived disease incidence and winter housing on organic and non-organic dairy farms in the UK. J Dairy Res. 2008, 76 (1): 6-14. 10.1017/S0022029908003622.
LeBlanc SJ, Lissemore KD, Kelton DF, et al: Major advances in disease prevention in dairy cattle. J Dairy Sci. 2006, 89 (4): 1267-1279. 10.3168/jds.S0022-0302(06)72195-6.
Leigh JA: Streptococcus uberis: a permanent barrier to the control of bovine mastitis?. Vet J. 1999, 157 (3): 225-238. 10.1053/tvjl.1998.0298.
Leigh JA, Field TR, Williams MR: Two strains of Streptococcus uberis, of differing ability to cause clinical mastitis, differ in their ability to resist some host defence factors. Res Vet Sci. 1990, 49 (1): 85-87.
Leigh JA, Ward PN, Field TR: The exploitation of the genome in the search for determinants of virulence in Streptococcus uberis. Vet Immunol Immunopathol. 2004, 100 (3-4): 145-149. 10.1016/j.vetimm.2004.04.004.
Licitra G, Blake RW, Oltenacu PA, et al: Assessment of the dairy production needs of cattle owners in southeastern Sicily. J Dairy Sci. 1998, 81 (9): 2510-2517. 10.3168/jds.S0022-0302(98)70143-2.
Lippolis JD, Reinhardt TA: Proteomic survey of bovine neutrophils. Vet Immunol Immunopathol. 2005, 103 (1-2): 53-65. 10.1016/j.vetimm.2004.08.019.
Lopez-Benavides MG, Williamson JH, Pullinger GD, et al: Field observations on the variation of Streptococcus uberis populations in a pasture-based dairy farm. J Dairy Sci. 2007, 90 (12): 5558-5566. 10.3168/jds.2007-0194.
Lovett DK, Shalloo L, Dillon P, et al: A systems approach to quantify greenhouse gas fluxes from pastoral dairy production as affected by management regime. Agr Systems. 2006, 88 (2-3): 156-179. 10.1016/j.agsy.2005.03.006.
Manning S, Tallman P, Foxman B: Prevalence and co-colonisation with group b streptococcus (GBS) among heterosexual college couples. Ann Epidemiol. 2000, 10 (7): 472-10.1016/S1047-2797(00)00132-0.
Matthews KR, Almeida RA, Oliver SP: Bovine mammary epithelial cell invasion by Streptococcus uberis. Infect Immun. 1994, 62 (12): 5641-5646.
McAllister AJ: Is crossbreeding the answer to questions of dairy breed utilisation?. J Dairy Sci. 2002, 85 (9): 2352-2357. 10.3168/jds.S0022-0302(02)74315-4.
McDougall S: Intramammary treatment of clinical mastitis of dairy cows with a combination of lincomycin and neomycin, or penicillin and dihydrostreptomycin. N Z Vet J. 2003, 51 (3): 111-116. 10.1080/00480169.2003.36349.
McDougall S, Parkinson TJ, Leyland M, et al: Duration of infection and strain variation in Streptococcus uberis isolated from cows' milk. J Dairy Sci. 2004, 87 (7): 2062-2072. 10.3168/jds.S0022-0302(04)70024-7.
Mehrzad J, Duchateau L, Burvenich C: Viability of milk neutrophils and severity of bovine coliform mastitis. J Dairy Sci. 2004, 87 (12): 4150-4162. 10.3168/jds.S0022-0302(04)73558-4.
Meyn LA, Moore DM, Hillier SL, et al: Association of sexual activity with colonisation and vaginal acquisition of group B Streptococcus in nonpregnant women. Am J Epidemiol. 2002, 155 (10): 949-957. 10.1093/aje/155.10.949.
Middleton JR, Fox LK: Influence of Staphylococcus aureus strain on mammary quarter milk production. Vet Rec. 2002, 150 (13): 411-413. 10.1136/vr.150.13.411.
Mikko S, Andersson L: Low major histocompatibility complex class II diversity in European and North American moose. Proc Nat Acad Sci USA. 1995, 92 (10): 4259-4263. 10.1073/pnas.92.10.4259.
Milne MH, Barrett DC, Fitzpatrick JL, et al: Prevalence and aetiology of clinical mastitis on dairy farms in Devon. Vet Rec. 2002, 151 (8): 241-243. 10.1136/vr.151.8.241.
Milne MH, Biggs AM, Barrett DC, et al: Treatment of persistent intramammary infections with Streptococcus uberis in dairy cows. Vet Rec. 2005, 157 (9): 245-250.
Moon JS, Lee AR, Kang HM, et al: Phenotypic and genetic antibiogram of methicillin-resistant staphylococci isolated from bovine mastitis in Korea. J Dairy Sci. 2007, 90 (3): 1176-1185. 10.3168/jds.S0022-0302(07)71604-1.
Msanga YN, Bryant MJ, Rutam IB, et al: Effect of environmental factors and of the proportion of Holstein blood on the milk yield and lactation length of crossbred dairy cattle on smallholder farms in north-east Tanzania. Trop Anim Health Prod. 2000, 32 (1): 23-31. 10.1023/A:1005288918672.
Mullarky IK, Su C, Frieze N, et al: Staphylococcus aureus agr genotypes with enterotoxin production capabilities can resist neutrophil bactericidal activity. Infect Immun. 2001, 69 (1): 45-51. 10.1128/IAI.69.1.45-51.2001.
Müller A, Schmidhuber J, Hoogeveen J, et al: Some insights in the effect of growing bioenergy demand on global food security and natural resources. Water Policy. 2008, 10 (S1): 83-94. 10.2166/wp.2008.053.
Mulligan FJ, O'Grady L, Rice DA, et al: A herd health approach to dairy cow nutrition and production diseases of the transition cow. Anim Reprod Sci. 2006, 96 (3-4): 331-353. 10.1016/j.anireprosci.2006.08.011.
Munoz MA, Ahlström C, Rauch BJ, et al: Fecal shedding of Klebsiella pneumoniae by dairy cows. J Dairy Sci. 2006, 89 (9): 3425-3430. 10.3168/jds.S0022-0302(06)72379-7.
Munoz MA, Welcome FL, Schukken YH, et al: Molecular epidemiology of two Klebsiella pneumoniae mastitis outbreaks on a dairy farm in New York State. J Clin Microbiol. 2007, 45 (12): 3964-3971. 10.1128/JCM.00795-07.
Myllys V, Asplund K, Brofeldt E, et al: Bovine mastitis in Finland in 1988 and 1995: changes in prevalence and antimicrobial resistance. Acta Vet Scand. 1998, 39 (1): 119-126.
Neave FK, Dodd FH, Kingwill RG, et al: Control of mastitis in the dairy herd by hygiene and management. J Dairy Sci. 1969, 52 (5): 696-707. 10.3168/jds.S0022-0302(69)86632-4.
Nielsen HM, Christensen LG, Odegård J: A method to define breeding goals for sustainable dairy cattle production. J Dairy Sci. 2006, 89 (9): 3615-3625. 10.3168/jds.S0022-0302(06)72401-8.
Nightingale C, Dhuyvetter K, Mitchell R, et al: Influence of variable milk quality premiums on observed milk quality. J Dairy Sci. 2008, 91 (3): 1236-1244. 10.3168/jds.2007-0609.
NMC: 2008, [Accessed December 7 2008], [http://www.nmconline.org/translations.html]
Oltenacu PA, Algers B: Selection for increased production and the welfare of dairy cows: are new breeding goals needed?. Ambio. 2005, 34 (4-5): 311-315.
Opsal MA, Lien S, Brenna-Hansen S, et al: Association analysis of the constructed linkage maps covering TLR2 and TLR4 with clinical mastitis in Norwegian Red cattle. J Anim Breed Genet. 2008, 125 (2): 110-118. 10.1111/j.1439-0388.2007.00704.x.
Østerås O, Sølverød L, Reksen O: Milk culture results in a large Norwegian survey-effects of season, parity, days in milk, resistance, and clustering. J Dairy Sci. 2006, 89 (3): 1010-1023. 10.3168/jds.S0022-0302(06)72167-1.
Park YH, Fox LK, Hamilton MJ, et al: Suppression of proliferative response of BoCD4+ T lymphocytes by activated BoCD8+ T lymphocytes in the mammary gland of cows with Staphylococcus aureus mastitis. Vet Immunol Immunopathol. 1993, 36 (2): 137-151. 10.1016/0165-2427(93)90103-B.
Patz JA, Campbell-Lendrum D, Holloway T, et al: Impact of regional climate change on human health. Nature. 2005, 438 (7066): 310-317. 10.1038/nature04188.
Paulin-Curlee GG, Singer RS, Sreevatsan S, et al: Genetic diversity of mastitis-associated Klebsiella pneumoniae in dairy cows. J Dairy Sci. 2007, 90 (8): 3681-3689. 10.3168/jds.2006-776.
Peeler EJ, Green MJ, Fitzpatrick JL, et al: The association between quarter somatic-cell counts and clinical mastitis in three British dairy herds. Prev Vet Med. 2003, 59 (3): 169-180. 10.1016/S0167-5877(03)00076-X.
Piepers S, de Meulemeester L, de Kruijff A, et al: Prevalence and distribution of mastitis pathogens in subclinically infected dairy cows in Flanders, Belgium. J Dairy Res. 2007, 74 (4): 478-483. 10.1017/S0022029907002841.
Pullinger GD, Lopez-Benavides M, Coffey TJ, et al: Application of Streptococcus uberis multilocus sequence typing: analysis of the population structure detected among environmental and bovine isolates from New Zealand and the United Kingdom. Appl Environ Microbiol. 2006, 72 (2): 1429-1436. 10.1128/AEM.72.2.1429-1436.2006.
Quality Milk Production Services. 2008, [Accessed December 7 2008], [http://qmps.vet.cornell.edu/education/milkertraining.htm]
Rainard P, Riollet C: Innate immunity of the bovine mammary gland. Vet Res. 2006, 37 (3): 369-400. 10.1051/vetres:2006007.
Rajala-Schultz PJ, Smith KL, Hogan JS, et al: Antimicrobial susceptibility of mastitis pathogens from first lactation and older cows. Vet Microbiol. 2004, 102 (1-2): 33-42. 10.1016/j.vetmic.2004.04.010.
Rendo F, Iriondo M, Jugo BM, et al: Analysis of the genetic structure of endangered bovine breeds from the Western Pyrenees using DNA microsatellite markers. Biochem Genet. 2004, 42 (3-4): 99-108. 10.1023/B:BIGI.0000020465.62447.00.
Rivas AL, González RN, Wiedmann M, et al: Diversity of Streptococcus agalactiae and Staphylococcus aureus ribotypes recovered from New York dairy herds. Am J Vet Res. 1997, 58 (5): 482-487.
Roesch M, Doherr MG, Blum JW: Management, feeding, production, reproduction and udder health on organic and conventional Swiss dairy farms. Schweiz Arch Tierheilkd. 2006, 148 (8): 387-395. 10.1024/0036-72220.127.116.117.
Rotz CA, Kamphuis GH, Karsten HD, et al: Organic dairy production systems in Pennsylvania: a case study evaluation. J Dairy Sci. 2007, 90 (8): 3961-3979. 10.3168/jds.2006-527.
Ruegg P: Management of mastitis on organic & conventional dairy farms. J Anim Sci Sep. 2008, 0:jas.2008-1217v1-jas.2008-1217
Sampimon OC, Sol J, Kock PA: Een uitbraak van Klebsiella pneumoniae mastitis. Tijdschr Diergeneeskd. 2006, 131 (1): 2-4. (English summary: An outbreak of Klebsiella pneumoniae mastitis)
Sampimon OC, Vernooij JC, Mevius DJ, et al: Gevoeligheid voor diverse antibiotica van coagulase negatieve staphylococcen, geïsoleerd uit melkmonsters van Nederlands rundvee. Tijdschr Diergeneeskd. 2007, 132 (6): 200-204. (English summary: Sensitivity to various antibiotics of coagulase-negative staphylococci isolated from samples of milk from Dutch dairy cattle)
Sharif S, Mallard BA, Wilkie BN: Characterisation of naturally processed and presented peptides associated with bovine major histocompatibility complex (BoLA) class II DR molecules. Anim Genet. 34 (2): 116-123. 10.1046/j.1365-2052.2003.00961.x.
Shkreta L, Talbot BG, Diarra MS, et al: Immune response to a DNA/protein vaccination strategy against Staphylococcus aureus induced mastitis in dairy cows. Vaccine. 2004, 23 (1): 114-126. 10.1016/j.vaccine.2004.05.002.
Shook GE: Major advances in determining appropriate selection goals. J Dairy Sci. 2006, 89 (4): 1349-1361. 10.3168/jds.S0022-0302(06)72202-0.
Smith EM, Green LE, Medley GF, et al: Multilocus sequence typing of intercontinental bovine Staphylococcus aureus isolates. J Clin Microbiol. 2005, 43 (9): 4737-4743. 10.1128/JCM.43.9.4737-4743.2005.
Smith TH, Fox LK, Middleton JR: Outbreak of mastitis caused by one strain of Staphylococcus aureus in a closed dairy herd. J Am Vet Med Assoc. 1998, 212 (4): 553-556.
Smolenski G, Haines S, Kwan FY, et al: Characterisation of host defence proteins in milk using a proteomic approach. J Proteome Res. 2007, 6 (1): 207-15. 10.1021/pr0603405.
Sukhnanand S, Dogan B, Ayodele MO, et al: Molecular subtyping and characterisation of bovine and human Streptococcus agalactiae isolates. J Clin Microbiol. 2005, 43 (3): 1177-1186. 10.1128/JCM.43.3.1177-1186.2005.
Suriyasathaporn W, Heuer C, Noordhuizen-Stassen EN, et al: Hyperketonemia and the impairment of udder defense: a review. Vet Res. 2000, 31 (4): 397-412. 10.1051/vetres:2000128.
Suriyasathaporn W, Schukken YH, Nielen M, et al: Low somatic cell count: a risk factor for subsequent clinical mastitis in a dairy herd. J Dairy Sci. 2000, 83 (6): 1248-1255. 10.3168/jds.S0022-0302(00)74991-5.
Tamilselvam B, Almeida RA, Dunlap JR, et al: Streptococcus uberis internalises and persists in bovine mammary epithelial cells. Microb Pathog. 2006, 40 (6): 279-285. 10.1016/j.micpath.2006.02.006.
Taverna F, Negri A, Piccinini R, et al: Characterization of cell wall associated proteins of a Staphylococcus aureus isolated from bovine mastitis case by a proteomic approach. Vet Microbiol. 2007, 119 (2-4): 240-247. 10.1016/j.vetmic.2006.09.007.
Tenhagen BA, Koster G, Wallmann J, et al: Prevalence of mastitis pathogens and their resistance against antimicrobial agents in dairy cows in Brandenburg, Germany. J Dairy Sci. 2006, 89 (7): 2542-2551. 10.3168/jds.S0022-0302(06)72330-X.
Tolboom RK, Snoep JJ, Sampimon OC, et al: Mycoplasma mastitis bij het rund. Tijdschr Diergeneeskd. 2008, 133 (3): 96-101. (English summary Mycoplasma mastitis in dairy cattle)
Tomita T, Meehan B, Wongkattiya N, et al: Identification of Streptococcus uberis multilocus sequence types highly associated with mastitis. Appl Environ Microbiol. 2008, 74 (1): 114-124. 10.1128/AEM.01373-07.
Tomkins A: Malnutrition, morbidity and mortality in children and their mothers. Proc Nutr Soc. 2000, 59 (1): 135-146. 10.1017/S0029665100000161.
UN: World population prospects: The 2004 revision. 2004, [Accessed December 7 2008], [http://www.un.org/esa/population/publications/WPP2004/WPP2004_Volume3.htm]
University of Wisconsin: 2008, [Accessed December 7 2008], [http://www.uwex.edu/milkquality/Spanish_Resources/index.htm]
Vage DI, Lingaas F, Spooner RL, et al: A study on association between mastitis and serologically defined class I bovine lymphocyte antigens (BoLA-A) in Norwegian cows. Anim Genet. 1992, 23 (6): 533-536. 10.1111/j.1365-2052.1992.tb00174.x.
Van Loo I, Huijsdens X, Tiemersma E, et al: Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis. 2007, 13 (12): 1834-1839.
VanRaden PM: Invited review: selection on net merit to improve lifetime profit. J Dairy Sci. 2004, 87 (10): 3125-3131. 10.3168/jds.S0022-0302(04)73447-5.
Vecht U, Meijers KC, Wisselink HJ: Klebsiella pneumoniae mastitis als bedrijfsprobleem. Tijdschr Diergeneeskd. 1987, 112 (11): 653-659. (English summary: Klebsiella pneumoniae mastitis as a dairying problem)
Vicini J, Etherton T, Kris-Etherton P, et al: Survey of retail milk composition as affected by label claims regarding farm-management practices. J Am Dietetic Assoc. 2008, 108 (7): 1198-1203. 10.1016/j.jada.2008.04.021.
Weigel KA, Freeman AE, Kehrli ME, et al: Assocation of class I bovine lymphocyte antigen complex alleles with health and production traits in dairy cattle. J Dairy Sci. 1990, 73 (9): 2538-2546. 10.3168/jds.S0022-0302(90)78939-4.
Wein LM, Liu Y: Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk. Proc Natl Acad Sci USA. 2005, 102 (28): 9984-9989. 10.1073/pnas.0408526102.
Whist AC, Østerås O, Sølverød L: Streptococcus dysgalactiae isolates at calving and lactation performance within the same lactation. J Dairy Sci. 2007, 90 (2): 766-778. 10.3168/jds.S0022-0302(07)71561-8.
Wicks HC, Leaver JD: Influence of genetic merit and environment on somatic cell counts of Holstein-Friesian cows. Vet J. 2006, 172 (1): 52-57. 10.1016/j.tvjl.2005.02.027.
Wieliczko RJ, Williamson JH, Cursons RT, et al: Molecular typing of Streptococcus uberis strains isolated from cases of bovine mastitis. J Dairy Sci. 2002, 85 (9): 2149-2154. 10.3168/jds.S0022-0302(02)74293-8.
Wilson DJ, González RN, Das HH: Bovine mastitis pathogens in New York and Pennsylvania: prevalence and effects on somatic cell count and milk production. J Dairy Sci. 1997, 80 (10): 2592-2598. 10.3168/jds.S0022-0302(97)76215-5.
Yamagata M, Goodger WJ, Weaver L, et al: The economic benefit of treating subclinical Streptococcus agalactiae mastitis in lactating cows. J Am Vet Med Assoc. 1987, 191 (12): 1556-1561.
Yildirim AO, Lämmler C, Weiss R, et al: Pheno- and genotypic properties of streptococci of serological group B of canine and feline origin. FEMS Microbiol Lett. 2002, 212 (2): 187-192. 10.1111/j.1574-6968.2002.tb11265.x.
Zadoks R, van Leeuwen W, Barkema H, et al: Application of pulsed-field gel electrophoresis and binary typing as tools in veterinary clinical microbiology and molecular epidemiologic analysis of bovine and human Staphylococcus aureus isolates. J Clin Microbiol. 2000, 38 (5): 1931-1939.
Zadoks RN: Sources and epidemiology of Streptococcus uberis, with special emphasis on mastitis in dairy cattle. CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources. 2007, 2 (030): 15-
Zadoks RN, Schukken YH: Use of molecular epidemiology in veterinary practice. Vet Clin North Am Food Anim Pract. 2006, 22 (1): 229-261. 10.1016/j.cvfa.2005.11.005.
Zadoks RN, Watts JL: Species identification of coagulase-negative staphylococci: Genotyping is superior to phenotyping. Vet Microbiol. 2008, 134 (1-2): 20-28. 10.1016/j.vetmic.2008.09.012.
Zadoks RN, Gillespie BE, Barkema HW, et al: Clinical, epidemiological and molecular characteristics of Streptococcus uberis infections in dairy herds. Epidemiol Infect. 2003, 130 (2): 335-349. 10.1017/S0950268802008221.
Zadoks RN, van Leeuwen WB, Kreft D, et al: Comparison of Staphylococcus aureus isolates from bovine and human skin, milking equipment, and bovine milk by phage typing, pulsed-field gel electrophoresis, and binary typing. J Clin Microbiol. 2002, 40 (11): 3894-3902. 10.1128/JCM.40.11.3894-3902.2002.